{
  "zip": "10036",
  "sector": "Healthcare",
  "fullTimeEmployees": 5,
  "longBusinessSummary": "Neurotrope Bioscience, Inc. operates in the healthcare industry focusing on pharmaceutical business. The company engages in the research and development of bryostatin-1 in the treatment of alzheimer's disease. The company was incorporated in 2012 and is headquartered in New York, New York. Neurotrope Bioscience, Inc. operates independently of Neurotrope, Inc. as of December 2, 2020.",
  "city": "New York",
  "phone": "(973) 242-0005",
  "state": "NY",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.synaptogen.com",
  "maxAge": 1,
  "address1": "1185 Avenue of the Americas",
  "industry": "Biotechnology",
  "address2": "3rd Floor",
  "previousClose": 2.46,
  "regularMarketOpen": 2.5,
  "twoHundredDayAverage": 1.8825,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 3.15,
  "navPrice": null,
  "averageDailyVolume10Day": 104625,
  "totalAssets": null,
  "regularMarketPreviousClose": 2.46,
  "fiftyDayAverage": 1.8825,
  "trailingAnnualDividendRate": null,
  "open": 2.5,
  "averageVolume10days": 104625,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 2.4,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 332684,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": null,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 104625,
  "priceToSalesTrailing12Months": null,
  "dayLow": 2.4,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 332684,
  "fiftyTwoWeekHigh": 3.15,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.4,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 3.15,
  "exchange": "PNK",
  "shortName": "SYNAPTOGENIX INC",
  "longName": "Synaptogenix",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SNPX",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_268943522",
  "uuid": "d14ff140-0ac6-3af9-a386-f918dc6aa47f",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": 1.344,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": null,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": null,
  "netIncomeToCommon": -12352642,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": null,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": null,
  "enterpriseValue": -14625285,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 2.5,
  "logo_url": "https://logo.clearbit.com/synaptogen.com"
}